Son derece \u00f6l\u00fcmc\u00fcl beyin t\u00fcm\u00f6rlerinden biri olan glioblastoma ile m\u00fccadelede, Ohio Eyalet \u00dcniversitesi\u2019nde \u00e7al\u0131\u015fan ara\u015ft\u0131rmac\u0131lar, mevcut tedavi stratejilerini k\u00f6kten de\u011fi\u015ftirme potansiyeli ta\u015f\u0131yan yeni bir metabolik hedefi ke\u015ffetti. Bu \u00f6nc\u00fc \u00e7al\u0131\u015fma, h\u00fccre i\u00e7i \u00f6nemli s\u00fcre\u00e7leri d\u00fczenleyen heksozamin biyosentez yolundaki (HBP) kritik bir enzim olan fosfoglukomutaz 3\u2019\u00fc (PGM3) oda\u011f\u0131na al\u0131yor. Protein ve lipid glikozilasyonunu y\u00f6neten bu yolak, agresif t\u00fcm\u00f6rlerin h\u0131zl\u0131 \u00e7o\u011falmas\u0131n\u0131 ve hayatta kalmas\u0131n\u0131 do\u011frudan etkiliyor.<\/p>\n
Glioblastoma multiforme, h\u0131zl\u0131 h\u00fccre b\u00f6l\u00fcnmesi ve \u00e7evreleyen beyin dokusuna invazyon yetene\u011fiyle, hastalar i\u00e7in karamsar bir tablo ortaya koyuyor. Mevcut tedavi y\u00f6ntemleri, cerrahi m\u00fcdahale, radyasyon ve kemoterapi gibi se\u00e7enekler hastalar\u0131n ya\u015fam s\u00fcresinde sadece s\u0131n\u0131rl\u0131 olumlu etki yaratabiliyor ve tan\u0131 sonras\u0131 ortalama ya\u015fam s\u00fcresi 12-16 ay aras\u0131nda de\u011fi\u015fiyor. Bu nedenle, t\u00fcm\u00f6r\u00fcn temel metabolik i\u015fleyi\u015fini bozacak molek\u00fcler tabanl\u0131 tedavilerin geli\u015ftirilmesi b\u00fcy\u00fck bir gereklilik olarak \u00f6n plana \u00e7\u0131k\u0131yor.<\/p>\n
Bu yeni ara\u015ft\u0131rman\u0131n merkezinde, heksozamin biyosentez yolunda \u015feker fosfatlar\u0131n birbirine d\u00f6n\u00fc\u015f\u00fcm\u00fcn\u00fc sa\u011flayan PGM3 bulunuyor. HBP, UDP-N-asetilglukozamin (UDP-GlcNAc) sentezini destekleyen bir yol olarak, glikozilasyon i\u00e7in gerekli ana substrat\u0131 sa\u011fl\u0131yor. H\u00fccre i\u00e7indeki glikozilasyon olaylar\u0131, t\u00fcm\u00f6r h\u00fccrelerinin membran yap\u0131lar\u0131n\u0131, sinyal resept\u00f6rlerini ve metabolik enzimlerini stabilize ederek t\u00fcm\u00f6r\u00fcn metabolik esnekli\u011fini ve proliferasyonunu art\u0131r\u0131yor.<\/p>\n
Ohio Eyalet \u00dcniversitesi Kanser Metabolizmas\u0131 Merkezi\u2019nin kurucu direkt\u00f6r\u00fc Dr. Deliang Guo liderli\u011findeki ara\u015ft\u0131rma ekibi, PGM3\u2019\u00fcn rol\u00fcn\u00fc ayr\u0131nt\u0131l\u0131 deneysel modellerde inceledi. \u00c7al\u0131\u015fmada \u015fa\u015f\u0131rt\u0131c\u0131 bir \u015fekilde, lipid metabolizmas\u0131n\u0131n ana d\u00fczenleyicilerinden sterol d\u00fczenleyici element ba\u011flay\u0131c\u0131 protein 1\u2019in (SREBP-1) PGM3 hedeflemesiyle aktive olmas\u0131n\u0131n engellendi\u011fi g\u00f6zlemlendi. SREBP-1\u2019in normalde ya\u011f asidi sentezini destekleyerek h\u00fccre b\u00f6l\u00fcnmesi i\u00e7in gerekli membran yap\u0131m\u0131n\u0131 sa\u011flad\u0131\u011f\u0131 biliniyor. Ancak PGM3 inhibisyonunun, t\u00fcm\u00f6r b\u00fcy\u00fcmesi i\u00e7in kritik olan bu metabolik geri besleme mekanizmas\u0131n\u0131 tamamen \u00e7\u00f6kt\u00fcrd\u00fc\u011f\u00fc g\u00f6sterildi.<\/p>\n
Bu ke\u015fif, kanserin yaln\u0131zca genetik bir sorun olmad\u0131\u011f\u0131n\u0131, metabolik yeniden programlanman\u0131n da t\u00fcm\u00f6r hayatta kalmas\u0131nda temel rol oynad\u0131\u011f\u0131n\u0131 ortaya koyuyor. Glioblastoma h\u00fccreleri, enerji ve yap\u0131 materyali ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131lamak i\u00e7in heksozamin biyosentez ve lipid sentez yollar\u0131na b\u00fcy\u00fck \u00f6l\u00e7\u00fcde ba\u011fl\u0131 kal\u0131yor. PGM3 inhibisyonu, bu yollar\u0131 e\u015f zamanl\u0131 bloke ederek t\u00fcm\u00f6r geli\u015fimini etkili bi\u00e7imde durdurma potansiyeline sahip.<\/p>\n
Ara\u015ft\u0131rmalar, Fransa\u2019daki laboratuvarlar ve ABD\u2019den UCLA ile UC Irvine gibi \u00f6nde gelen \u00fcniversitelerin katk\u0131lar\u0131yla desteklendi. Bu i\u015f birli\u011fi, PGM3 engellemesinin farkl\u0131 h\u00fccresel ortam ve model sistemlerinde tekrarlanabilir ve g\u00fc\u00e7l\u00fc etkiler g\u00f6sterdi\u011fini kan\u0131tlad\u0131. B\u00f6ylece, PGM3\u2019\u00fcn glioblastoma t\u00fcrleri aras\u0131nda ortak bir metabolik zay\u0131fl\u0131k oldu\u011fu teyit edildi.<\/p>\n
Klinik a\u00e7\u0131dan bu \u00e7al\u0131\u015fma, PGM3 enzimini hedef alan yeni ila\u00e7 molek\u00fcllerinin geli\u015ftirilmesinin \u00f6n\u00fcn\u00fc a\u00e7\u0131yor. Bu tarz ajanlar, t\u00fcm\u00f6r metabolizmas\u0131n\u0131n \u00fcst basama\u011f\u0131nda etki yaratarak mevcut tedavi y\u00f6ntemlerine ek olarak diren\u00e7 mekanizmalar\u0131n\u0131n a\u015f\u0131lmas\u0131na ve t\u00fcm\u00f6r i\u00e7i heterojenitenin etkilerinin azalt\u0131lmas\u0131na katk\u0131 sa\u011flayabilir.<\/p>\n
Ara\u015ft\u0131rman\u0131n \u00f6nemli bir di\u011fer y\u00f6n\u00fc ise besin alg\u0131lama mekanizmas\u0131, metabolik ak\u0131\u015fkanl\u0131k ve onkogenik sinyalle\u015fmenin kompleks etkile\u015fimini ortaya koymas\u0131. Heksozamin sentez yolunun engellenmesi, glioblastoma h\u00fccrelerini kritik glikozilasyon bile\u015fenlerinden mahrum b\u0131rak\u0131yor; bu da h\u00fccre membran b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn bozulmas\u0131na, sinyal yollar\u0131n\u0131n aksamas\u0131na ve nihayetinde h\u00fccre \u00f6l\u00fcm\u00fcne ya da b\u00fcy\u00fcmenin durmas\u0131na yol a\u00e7\u0131yor.<\/p>\n
\u00c7al\u0131\u015fma, y\u00fcksek bilimsel kaliteyi temsil eden Science Advances dergisinde yay\u0131mland\u0131 ve Ulusal Sa\u011fl\u0131k Enstit\u00fcleri ile Urban and Shelly Meyer Vakf\u0131 gibi sayg\u0131n ara\u015ft\u0131rma fonlar\u0131ndan destek ald\u0131. Bu durum, bulgular\u0131n kanser ara\u015ft\u0131rmalar\u0131 a\u00e7\u0131s\u0131ndan \u00f6nemini ve g\u00fcvenilirli\u011fini peki\u015ftirdi.<\/p>\n
\u00c7al\u0131\u015fman\u0131n ilk yazar\u0131 Dr. Huali Su, glioblastoma tedavisinde uzun s\u00fcredir mevcut olan y\u00f6ntemlerin ba\u015far\u0131s\u0131zl\u0131\u011f\u0131 ve hayatta kalma oranlar\u0131n\u0131n iyile\u015fmemesi nedeniyle yeni molek\u00fcler hedeflerin ke\u015ffedilmesinin vazge\u00e7ilmez oldu\u011funu belirtti. PGM3 gibi metabolik enzimlerin tan\u0131mlanmas\u0131, geleneksel tedavilerin g\u00f6z ard\u0131 etti\u011fi sun\u00ee noktalara odaklanma f\u0131rsat\u0131 sa\u011fl\u0131yor.<\/p>\n
PGM3 hedefli tedavi yakla\u015f\u0131m\u0131 yaln\u0131zca glioblastoma ile s\u0131n\u0131rl\u0131 kalmayabilir. \u00c7\u00fcnk\u00fc benzer \u015fekilde heksozamin biyosentezi ve lipid metabolizmas\u0131na ba\u011f\u0131ml\u0131 di\u011fer agresif kanser t\u00fcrlerinde de etkili olabilir. Bu da t\u00fcm kanser t\u00fcrlerine y\u00f6nelik geni\u015f \u00e7apl\u0131 terap\u00f6tik stratejilerin geli\u015ftirilmesine olanak tan\u0131yor.<\/p>\n
Bu umut verici yakla\u015f\u0131m\u0131n klinik uygulamalara d\u00f6n\u00fc\u015f\u00fcm\u00fc i\u00e7in \u00f6n\u00fcm\u00fczdeki fazlarda, PGM3 inhibit\u00f6rlerinin canl\u0131 organizmalardaki etkinlik, toksisite profili ve mevcut tedavilerle birlikte kullan\u0131lma potansiyeli detayl\u0131 olarak incelenecek. Ba\u015far\u0131l\u0131 sonu\u00e7lar, beyin t\u00fcm\u00f6rleri ve di\u011fer malignitelerde tedavi paradigmas\u0131n\u0131n genetik temelden metabolik hedeflere kaymas\u0131n\u0131 sa\u011flayabilir.<\/p>\n
Sonu\u00e7 olarak, PGM3\u2019\u00fcn glioblastomada \u00f6nemli bir metabolik d\u00fczenleyici olarak tan\u0131mlanmas\u0131, uzun s\u00fcredir tedavi edilemez olarak kabul edilen bu hastal\u0131k kar\u015f\u0131s\u0131nda yeni umutlar ortaya koymaktad\u0131r. Karma\u015f\u0131k metabolik geri besleme d\u00f6ng\u00fclerinin hedeflenmesi, daha etkili ve spesifik kanser tedavilerinin geli\u015ftirilmesine zemin haz\u0131rlamaktad\u0131r. Gelece\u011fin glioblastoma y\u00f6netimi, bu derin biyokimyasal ke\u015fiflerin klinik tedavi y\u00f6ntemlerine d\u00f6n\u00fc\u015ft\u00fcr\u00fclmesinde yatabilir.<\/p>\n
—<\/p>\n
**Ara\u015ft\u0131rma Konusu**: H\u00fccreler
\n**Makale Ba\u015fl\u0131\u011f\u0131**: Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth
\n**Haberin Yay\u0131n Tarihi**: 18 Nisan 2025
\n**Web References**:
\n– The Ohio State University Comprehensive Cancer Center
\n– Glioblastoma Foundation
\n– Science Advances Journal
\n**Resim Credits**: The Ohio State University
\n**Anahtar Kelimeler**: Kanser ara\u015ft\u0131rmalar\u0131, Molek\u00fcler hedefler, Beyin t\u00fcm\u00f6rleri, Enzimler, T\u00fcm\u00f6r b\u00fcy\u00fcmesi, Glioblastoma, Akademik ara\u015ft\u0131rmac\u0131lar<\/p>\n","protected":false},"excerpt":{"rendered":"
Son derece \u00f6l\u00fcmc\u00fcl beyin t\u00fcm\u00f6rlerinden biri olan glioblastoma ile m\u00fccadelede, Ohio Eyalet \u00dcniversitesi\u2019nde \u00e7al\u0131\u015fan ara\u015ft\u0131rmac\u0131lar, mevcut tedavi stratejilerini k\u00f6kten de\u011fi\u015ftirme potansiyeli ta\u015f\u0131yan yeni bir metabolik hedefi ke\u015ffetti. Bu \u00f6nc\u00fc \u00e7al\u0131\u015fma, h\u00fccre i\u00e7i \u00f6nemli s\u00fcre\u00e7leri d\u00fczenleyen heksozamin biyosentez yolundaki (HBP) kritik bir enzim olan fosfoglukomutaz 3\u2019\u00fc (PGM3) oda\u011f\u0131na al\u0131yor. Protein ve lipid glikozilasyonunu y\u00f6neten bu yolak,…<\/p>\n","protected":false},"author":1,"featured_media":3164,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[1474,1476,1475,1477,1473],"tmauthors":[],"class_list":{"0":"post-3163","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-fosfoglukomutaz-3-pgm3-inhibisyonu","9":"tag-glioblastoma-metabolik-yeniden-programlanmasi","10":"tag-heksozamin-biyosentez-yolunun-kanser-rolu","11":"tag-kanser-lipid-ve-protein-glikozilasyon-mekanizmalari","12":"tag-yuksek-riskli-glioblastoma-tedavi-hedefleri"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/Yuksek-Riskli-Beyin-Kanserinde-Kritik-Enzim-Hedefi-1745000966.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=3163"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3163\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/3164"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=3163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=3163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=3163"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=3163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}